US Patent Issued to JIANGSU KANION PHARMACEUTICAL on Feb. 24 for "Application of traditional Chinese medicine composition to preparation of medicine for treating or preventing coronavirus infection" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,394, issued on Feb. 24, was assigned to JIANGSU KANION PHARMACEUTICAL Co. LTD. (Lianyungang, China).

"Application of traditional Chinese medicine composition to preparation of medicine for treating or preventing coronavirus infection" was invented by Wei Xiao (Lianyungang, China), Xiaoqian Tao (Lianyungang, China), Xinzhuang Zhang (Lianyungang, China), Zhenzhen Su (Lianyungang, China), Zhipeng Ke (Lianyungang, China), Zeyu Cao (Lianyungang, China), Liang Cao (Lianyungang, China), Xiaolian He (Lianyungang, China), Xuehong Dong (Lianyungang, China) and Yanqiu Wang (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Application of a trad...